Nike's Signature Shoe Release May Be Its Biggest Test Yet

Nike is facing two major tests this week, but its earnings report on Thursday isn't expected to be the highlight. The company's stock has been trading near decade lows, and analysts are lowering their expectations for a comeback.

Last Friday, Bank of America downgraded Nike to underperform and reduced its price target from $47 to $30 due to concerns over earnings over the next two years. Three other analysts slashed their price targets on Monday as well, reflecting Nike's decline in recent months.

The company is expecting a 3.3% decline in revenue to $11.33 billion and a drop in earnings per share from $0.49 to $0.44, creating a low bar for the company to overcome.

However, Nike's release of Caitlin Clark's first signature shoe on Thursday could be the catalyst long-term investors are looking for. The shoe, which retails for $140 and features interlocking Cs reminiscent of the 'Jumpman' logo, may indicate Nike's ability to leverage star power and build a new franchise.

The Caitlin 1 release will include an 18-piece apparel collection featuring hoodies, jackets, and t-shirts, as well as Nike's new Opticast innovation, which supports lateral quickness. The shoe's success could be crucial for Nike's turnaround, especially after losing French soccer star Kylian Mbappe to On earlier this month.